BioLamina
Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.
About
BioLamina is a Stockholm-based biotech scale-up specializing in matrix biology and cell culture. Founded in 2009, the company develops and manufactures high-quality, chemically defined, and animal-origin-free human recombinant laminin-based cell culture substrates. These substrates are designed to enable the reliable growth and differentiation of pluripotent stem cells and other primary cells, which are crucial for advancing cell therapies for serious chronic diseases and enhancing the precision of cell-based models in drug discovery and development. Teams look it up for Biotechnology, Life Sciences, HealthTech.
Frequently asked
What does BioLamina do?
BioLamina is a Biotechnology company that offers Services. Teams look it up for Life Sciences, HealthTech, Cell Therapy. It is based in Stockholm, Sweden and was founded in 2009. It was formerly known as []. Public records show $42M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has BioLamina raised?
BioLamina has raised a total of $42M in funding. The most recent round on record is Venture Debt.
Where is BioLamina headquartered?
BioLamina is headquartered in Stockholm, Sweden.
When was BioLamina founded?
BioLamina was founded in 2009.
What industry does BioLamina operate in?
BioLamina operates in Biotechnology, Life Sciences, HealthTech, Cell Therapy, Biotech.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.